Go to article: Home | Radiopharmaceutical deals drive sector growth despite supply crisisGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: NiproGo to article: In DepthGo to article: Radiopharmaceutical deals drive sector growth despite supply crisisGo to article: Treating alcohol addiction: filling the medication gap Go to article: Trump’s tariffs will trickle down the clinical trial chain Go to article: The AI advantage in discovering new medicinesGo to article: EU reshapes HTAs: is the industry ready for it?Go to article: Obesity market to reach $173.5bn by 2031Go to article: People-focused cancer care demands policy supportGo to article: Endress+HauserGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Excellence Awards 2024: IFF Pharma SolutionsGo to article: Buyer's GuidesGo to article: Next issue